The effect of sesame-canola oil compared to sesame and canola oil on patients with type 2 diabetes and their spouse

Conditions

Condition 1: Non-insulin-dependent diabetes mellitus. Condition 2: Spouses. Non-insulin-dependent diabetes mellitus

Amiri M, Raeisi-Dehkordi H, Moghtaderi F, Zimorovat A, Mohyadini M, Salehi-Abargouei A.

2022-05-215 citations

The effect of sesame, canola, and sesame‐canola oils on cardiometabolic risk factors in overweight adults: a three‐way randomized triple‐blind crossover clinical trial

Fatemeh Moghtaderi, Mojgan Amiri, Hamidreza Raeisi‐Dehkordi, Alireza Zimorovat, Matin Mohyadini et al. (6 authors)

Phytotherapy Research2022-01-239 citations

10.1002/ptr.7381

Canola oil compared with sesame and sesame‐canola oil on glycaemic control and liver function in patients with type 2 diabetes: A three‐way randomized triple‐blind cross‐over trial

Hamidreza Raeisi‐Dehkordi, Mojgan Amiri, Alireza Zimorovat, Fatemeh Moghtaderi, Sadegh Zarei et al. (7 authors)

Diabetes/Metabolism Research and Reviews2020-08-2927 citations

10.1002/dmrr.3399

The effect of canola, sesame and sesame-canola oils on body fat and composition in adults: a triple-blind, three-way randomised cross-over clinical trial

Fatemeh Moghtaderi, Mojgan Amiri, Alireza Zimorovat, Hamidreza Raeisi‐Dehkordi, Masoud Rahmanian et al. (8 authors)

International Journal of Food Sciences and Nutrition2020-07-208 citations

10.1080/09637486.2020.1786024

Interventions

Intervention 1: Intervention: Sesame-canola oli. Intervention 2: control: sesame oil. Intervention 3: Control: Canola oil.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Adults aged between 18-60 years old With clinically diagnosed type 2 diabetes for at least 6-month and maximum of 10 years With hemoglubin A1C lower than 8 percent Only take oral anti-hyperglycemic agents for the treatment have intention to enter the study and fill the informed consent

Exclusion criteria

Exclusion criteria: Being on insulin therapy History of known Cardiovascular Diseases (Coronary Artery Disease, Stroke, Congestive heart disease) Coronary artery bypass grafting (CABG) History of kidney or liver disease [alanine aminotransferase (ALT) and aspartate aminotransferase (AST) three times more than normal values] history of cancer Changing the dose of lipid lowering medications for at least 3 months prior starting the study being pregnant

Design outcomes

Primary

Measure	Time frame
Serum high density lipoprotein cholesterol (HDL-C). Timepoint: start and the end of each intervention period. Method of measurement: Using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum fasting blood sugar(FBS). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum low Density Lipoprotein cholesterol (LDL-C). Timepoint: start and the end of each intervention period. Method of measurement: Using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum Total cholesterol. Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum triglyceride level (TG). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.	—

Measure

Time frame

Serum high density lipoprotein cholesterol (HDL-C). Timepoint: start and the end of each intervention period. Method of measurement: Using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum fasting blood sugar(FBS). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum low Density Lipoprotein cholesterol (LDL-C). Timepoint: start and the end of each intervention period. Method of measurement: Using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum Total cholesterol. Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Serum triglyceride level (TG). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.

—

Secondary

Measure	Time frame
BMI(body mass index). Timepoint: entrance and start and the end of each intervention period. Method of measurement: kg/m2.;Body Fat percent. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body composition analyzer.;Muscle mass percent. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body composition analyzer.;Weight. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body Calibrated scale.;Blood pressure. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by Barometer.;Insulin. Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate ELISA kit.;Lipoprotein(a). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Apo lipoprotein A (Apo A). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Apo lipoprotein B(Apo B). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Alkaline phosphatase ( ALP). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Alanine aminotransferase (ALT). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Aspartate aminotransferase (AST). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Gama glutamil transferase (GGT). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Urea. Timepoint: start and the end of each intervention peri	—

Measure

Time frame

BMI(body mass index). Timepoint: entrance and start and the end of each intervention period. Method of measurement: kg/m2.;Body Fat percent. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body composition analyzer.;Muscle mass percent. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body composition analyzer.;Weight. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by body Calibrated scale.;Blood pressure. Timepoint: entrance and start and the end of each intervention period. Method of measurement: by Barometer.;Insulin. Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate ELISA kit.;Lipoprotein(a). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Apo lipoprotein A (Apo A). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Apo lipoprotein B(Apo B). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Alkaline phosphatase ( ALP). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Alanine aminotransferase (ALT). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Aspartate aminotransferase (AST). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Gama glutamil transferase (GGT). Timepoint: start and the end of each intervention period. Method of measurement: using Appropriate kits, by Alpha-Classic autoanalyzer.;Urea. Timepoint: start and the end of each intervention peri

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojgan Amiri

Nutrition and Food security Research Center, Faculty of Health, Shahid Sadoughi University of Medica

mojgan.amiri2015@yahoo.com+98 35 3820 9100

Outcome results

None listed